Skip to main content
. 2020 Apr 20;69(8):1627–1637. doi: 10.1007/s00262-020-02573-0

Fig. 4.

Fig. 4

Survival analyses comparing prognostic groups. Kaplan-Meier analysis of a recurrence-free survival (RFS) of immune PD-L1+/− groups. b RFS of immune PD-L1+/− groups, stratified for EMAST status. c RFS of Immunoscore groups (low-intermediate-high). d Disease-specific survival (DSS) of immune PD-L1+/− groups